Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Carlyn Rose C. Tan"'
Autor:
Joe L. Hsu, Gowri Satyanarayana, Vincent T. Ho, Vijaya Raj Bhatt, Mohamed Kharfan Dabaja, Lenora A. Pluchino, Javier Bolanos Meade, Areej El-Jawahri, Jonathan A. Gutman, Ayman Saad, Julianna Roddy, Marco Mielcarek, Antonio Di Stasi, Mitchell E. Horwitz, Jonathan Moreira, Carlyn Rose C. Tan, Ryotaro Nakamura, Mark A. Schroeder, Alison W. Loren, George Chen, Jennifer L. Burns, Sarah Anand, Daniel R. Couriel, Mark B. Juckett, Dimitrios Tzachanis, Ryan Bookout, Marcos de Lima, Sergio Giralt, Yago Nieto
Publikováno v:
Journal of the National Comprehensive Cancer Network. 18:599-634
Hematopoietic cell transplantation (HCT) involves the infusion of hematopoietic progenitor cells into patients with hematologic disorders with the goal of re-establishing normal hematopoietic and immune function. HCT is classified as autologous or al
Autor:
Stefan K. Barta, Joseph A. Sparano, Michelle A. Rudek, Carlyn Rose C. Tan, Ariela Noy, Jeannette Y. Lee
Publikováno v:
Leukemia & Lymphoma. 59:1851-1860
Drug-drug interactions between cART and chemotherapy may impact HIV and lymphoma control or lead to increased toxicities. No prospective comparative data informs potential harms and benefits. In AMC034 HIV-associated high-grade B-cell NHL patients re
Autor:
Ellen Kim, Karthik Devajaran, David L. Wiest, Carlyn Rose C. Tan, Jennifer DeSimone, Nadia Khan, Richard I. Fisher, Henry C.H. Fung, Stefan K. Barta, Tatyana Feldman
Publikováno v:
Blood. 136:24-25
Introduction: While most patients (pts) with cutaneous T-cell lymphoma (CTCL) have an indolent course, survival for stages ≥IIB is usually less than 5 years (Kim YH et al, Arch Dermatol 2003). When an aggressive approach of combination cytotoxic th
Publikováno v:
Current Colorectal Cancer Reports. 12:151-161
Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) are emerging noninvasive multifunctional biomarkers in liquid biopsy allowing for early diagnosis, accurate prognosis, therapeutic target selection, spatiotemporal monitoring of metasta
Autor:
Henry C. Fung, Jasmine Zain, Nathan Fowler, Carlyn Rose C. Tan, Paul Fields, Stefan K. Barta, Yang Liu, Yasuhiro Oki, R. Katherine Alpaugh, Pooja Phull
Publikováno v:
Precision Cancer Medicine. 3:31-31
Autor:
Richard I. Fisher, Henry C. Fung, Yibin Yang, Eric A. Ross, Alexander W. MacFarlane, Nathan Fowler, Sonali M. Smith, Nadia Khan, Carlyn Rose C. Tan, Yasuhiro Oki, Kerry S. Campbell, Stefan K. Barta, R. Katherine Alpaugh, Jia Ruan, Essel Dulaimi, Jasmine Zain, Rawat Siddharta
Publikováno v:
Clin Lymphoma Myeloma Leuk
Background Programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) are frequently expressed in T-cell lymphomas. This provides a rationale for exploration of immune checkpoint inhibitors in the management of T-cell lymphomas. Patients an
Publikováno v:
Clinical pharmacokinetics. 58(2)
Proteasome inhibitors disrupt multiple pathways in cells and the bone marrow microenvironment, resulting in apoptosis and inhibition of cell-cycle progression, angiogenesis, and proliferation. Bortezomib is a first-in-class proteasome inhibitor appro
Autor:
Sonali M. Smith, Kerry S. Campbell, Jasmine Zain, Richard I. Fisher, Daniel J. Landsburg, Stephen J. Schuster, Elise A. Chong, Carlyn Rose C. Tan, Henry C. Fung, Sunita D. Nasta, Jakub Svoboda, Nathan Fowler, Nadia Khan, Jia Ruan, Stefan K. Barta, James N. Gerson
Publikováno v:
Blood. 134:4031-4031
Background: Outcomes for relapsed or refractory mature T-cell lymphomas (RR TCL) are poor and have remained largely stagnant despite approval of several novel single agents in this setting over the last decade (Chihara D, et al. Br J Haematol. 2017).
Publikováno v:
Blood. 134:1595-1595
Background: Plasmablastic lymphoma (PBL) is an aggressive large B-cell lymphoma commonly associated with HIV, immunosuppression, old age, and autoimmune disorders, but can be seen in immunocompetent patients. Intensive regimens, including EPOCH, have
Autor:
Philip A. Pancari, Henry C. Fung, Stefan K. Barta, Jordan Senchak, James Michael Martin, Carlyn Rose C. Tan, Brittany Cael, Karthik Devarajan
Publikováno v:
Web of Science
Introduction Cytomegalovirus (CMV) reactivation remains a common cause of morbidity and mortality following allogeneic hematopoietic cell transplant (HCT) despite attempts at prophylaxis. Following transplantation, surveillance of the peripheral bloo